Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recent research from the Simon and Jacobsen groups reveals an unexpected role for autophagy in neutrophil development.

Neutrophils are cells of the immune system, essential for fighting bacterial and fungal infections. Within the human bone marrow, one million neutrophils are generated every second, a rapid and complex process requiring substantial energy and key to the body’s immune response to infection. However, the mechanisms that regulate this process are not fully understood, and dysfunctional neutrophil differentiation can lead to disease.

In their latest publication in Immunity, Researchers at the Simon and Jacobsen labs at the MRC WIMM (Radcliffe Department of Medicine) and Kennedy Institute (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) report that autophagy, an intracellular self-eating process, is necessary for successful neutrophil differentiation. Through autophagy, neutrophil precursor cells are able to degrade lipid droplets, which releases fatty acids. This allows a metabolic switch from glycolysis to free fatty acid oxidation, which the researchers have shown to be essential for neutrophil maturation. 

Many myeloid leukemias are characterised by defective differentiation and precursor cell accumulation, and autophagy defects have been reported. The next goal for the researchers is to test whether a metabolic rewiring dependent on autophagy similar to that observed in neutrophils may also take place in acute myebloastic leukemias.

 

Find out more:

Riffelmacher T., et al (2017) Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation, Immunity, 47 466-480

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.